Cells from patients with this inherited disorder have an overactivated cellular response to oxidative stress. This is caused by an activation of an atypical signaling pathway in which the RAF, MKK3 and p38 proteins participate
The party, organized by the Debut restaurant, the Can Tisores hairdresser, Pessics de Ciencia, and IDIBELL had the participation of Álvaro Aytés, IDIBELL, and ICO researcher.
The Movember party in L’Hospitalet raises money for prostate cancer Research Read More »
This is the eighth version of the Standards of Care for the Health of Transgender and Gender Diverse People, which aim to provide clinical guidance to health professionals to maximize their overall health, psychological well-being, and self-fulfillment.
New guidelines for health care of transgender and gender diverse people Read More »
A team from IDIBELL, UB, and the Neuroscience Institute observed that the lack of interaction between two neuronal adenosine receptors could be responsible for the alteration of brain circuits in early or juvenile Parkinson’s disease.
Researchers define the molecular mechanism associated with juvenile Parkinson’s Read More »
The project led by Dr. Maria del Pino Alonso, from IDIBELL and HUB, will receive almost 400,000 euros to search for new biomarkers predicting the long-term evolution of OCD.
La Marató funds a project on obsessive-compulsive disorder Read More »
An epidemiological study co-led by IDIBELL, the Catalan Institute of Oncology (ICO), and Harvard University (Boston, USA) observed that coffee consumption could have a protective effect against the risk of suffering endometrial cancer.
Coffee could have a protective effect against endometrial cancer Read More »
The Cervell(s) exhibition delves into this organ from different artistic, historical, and scientific perspectives, including the results of real projects such as the case of Dr. Sandra Acosta.
Doctors Maria Molina and Vanesa Vicens Zygmunt presented the results of the MADIET clinical trial at the International Fibrosis Congress. The clinical trial was coordinated by the Pulmonology research group from IDIBELL and the Bellvitge University Hospital (HUB) with the participation of hospitals from six European countries.
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
This Saturday, the Bellvitge Campus opened its doors to bring the research of one of the most important biomedical centers in the country closer to the public. With activities such as guided tours, talks, escape rooms, and gymkhanas the event had a great attendance success.
Great success at the Sinergia 2022 Open Day Read More »
